Stay updated on Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T23:28:49.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed descriptions of a Phase 3 trial for cabozantinib in combination with nivolumab and ipilimumab, while retaining key information about the study's randomization and subject eligibility criteria.
    Difference
    18%
    Check dated 2025-04-17T11:08:46.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 11, 2025, while a previous date of March 25, 2025, has been removed.
    Difference
    0.3%
    Check dated 2025-04-10T06:20:57.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    72 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-25T19:15:15.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page has updated its status to 'Active, not recruiting' and has revised several important dates related to its timeline, including the removal of past dates and the addition of future estimated dates.
    Difference
    0.7%
    Check dated 2025-02-18T13:58:42.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1.0%
    Check dated 2025-02-11T10:12:55.000Z thumbnail image

Stay in the know with updates to Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.